6390
C. S. Cho, D. B. Patel / Tetrahedron 62 (2006) 6388–6391
intrinsic C–N bond protocol. The present reaction is a new
route for the synthesis of pyrazoles from ketones.
23.16, 23.55, 117.45, 122.99, 129.56, 136.43, 137.70,
138.11, 138.47; Anal. Calcd for C14H16N2: C 79.21; H
7.60; N 13.20; found: C 79.08; H 7.81; N 13.06.
3. Experimental
3.1. General
3.2.4. 1-(4-Methoxyphenyl)-4,5,6,7-tetrahydro-1H-inda-
zole (3e). Oil; H NMR (400 MHz, CDCl3) d 1.74–1.86
1
(m, 4H), 2.56–2.59 (m, 2H), 2.64–2.67 (m, 2H), 3.83 (s,
3H), 6.93–6.97 (m, 2H), 7.36–7.40 (m, 2H), 7.42 (s, 1H);
13C NMR (100 MHz, CDCl3) d 21.12, 23.26, 23.50, 23.69,
55.90, 114.54, 117.58, 125.10, 133.79, 138.56, 138.63,
158.73; Anal. Calcd for C14H16N2O: C 73.66; H 7.06; N
12.27; found: C 73.51; H 7.31; N 12.24.
1H and 13C NMR (400 and 100 MHz) spectra were recorded
on a Bruker Avance Digital 400 spectrometer using TMS as
an internal standard. Melting points were determined on
a Thomas–Hoover capillary melting point apparatus and
were uncorrected. The isolation of pure products was carried
out via thin layer (silica gel 60 GF254, Merck) chromato-
graphy. b-Bromovinyl aldehydes 1 were prepared by the
reported methods.11 Commercially available organic and
inorganic compounds were used without further purification
except for toluene, THF, and MeCN, which were distilled by
known methods before use.
3.2.5. 1-(2-Trifluoromethylphenyl)-4,5,6,7-tetrahydro-
1H-indazole (3f). Oil; 1H NMR (400 MHz, CDCl3)
d 1.72–1.81 (m, 4H), 2.33–2.36 (m, 2H), 2.57–2.59 (m,
2H), 7.34 (d, J¼7.5 Hz, 1H), 7.46 (s, 1H), 7.57 (t,
J¼7.5 Hz, 1H), 7.62–7.66 (m, 1H), 7.79–7.81 (m, 1H); 13C
NMR (100 MHz, CDCl3) d 20.92, 21.98, 23.09, 23.36,
116.73, 123.31 (q, J¼272.4 Hz), 127.72 (q, J¼4.8 Hz),
128.68 (q, J¼31.2 Hz), 129.65, 130.56, 132.87, 138.01 (q,
J¼1.9 Hz), 139.01, 140.82; Anal. Calcd for C14H13F3N2:
C 63.15; H 4.92; N 10.52; found: C 63.41; H 5.04; N 10.54.
3.2. Typical procedure for palladium-catalyzed synthe-
sis of pyrazoles from b-bromovinyl aldehydes and
arylhydrazines
A mixture of 2-bromocyclohex-1-enecarbaldehyde (1a)
(0.189 g, 1 mmol), phenylhydrazine (2a) (0.108 g,
1 mmol), Pd(OAc)2 (0.011 g, 0.05 mmol), dppf (0.042 g,
0.075 mmol), and NaOtBu (0.192 g, 2 mmol) in toluene
(10 mL) was placed in a 50 mL pressure vessel. After the
system was flushed with argon, the mixture was stirred at
125 ꢀC for 24 h. The reaction mixture was passed through
a short silica gel column (ethyl acetate) to eliminate inor-
ganic salts. Removal of the solvent left a crude mixture,
which was separated by thin layer chromatography (silica
gel, ethyl acetate/hexane¼1/10) to give 1-phenyl-4,5,6,7-
tetrahydro-1H-indazole (3a) (0.157 g, 79%). All new com-
pounds prepared by the above procedure were characterized
spectroscopically as shown below.
3.2.6. 1-Phenyl-1,4,5,6-tetrahydrocyclopentapyrazole
(3i). Oil; 1H NMR (400 MHz, CDCl3) d 2.57–2.69 (m,
4H), 2.97–3.01 (m, 2H), 7.20–7.24 (m, 1H), 7.38 (s, 1H),
7.39–7.43 (m, 2H), 7.62–7.65 (m, 2H); 13C NMR
(100 MHz, CDCl3) d 23.15, 26.85, 31.37, 119.41, 125.98,
129.64, 129.74, 135.20, 140.88, 148.90; Anal. Calcd for
C12H12N2: C 78.23; H 6.57; N 15.21; found: C 77.91; H
6.81; N 15.06.
3.2.7. 1-Phenyl-1,4,5,6,7,8-hexahydrocycloheptapyrazole
(3j). Solid (hexane/chloroform); mp 90 ꢀC; 1H NMR
(400 MHz, CDCl3) d 1.61–1.72 (m, 4H), 1.82–1.87 (m,
2H), 2.61–2.64 (m, 2H), 2.75–2.78 (m, 2H), 7.33–7.38 (m,
4H), 7.43–7.46 (m, 2H); 13C NMR (100 MHz, CDCl3)
d 26.05, 27.58, 27.63, 28.94, 32.23, 122.37, 125.86,
127.83, 129.30, 140.12, 140.41, 142.54; Anal. Calcd for
C14H16N2: C 79.21; H 7.60; N 13.20; found: C 79.22; H
7.72; N 12.99.
3.2.1. 1-(2-Methylphenyl)-4,5,6,7-tetrahydro-1H-inda-
zole (3b). Oil; H NMR (400 MHz, CDCl3) d 1.75–1.80
1
(m, 4H), 2.08 (s, 3H), 2.35–2.37 (m, 2H), 2.58–2.60
(m, 2H), 7.23–7.34 (m, 4H), 7.44 (s, 1H); 13C NMR
(100 MHz, CDCl3) d 17.44, 20.68, 21.90, 22.88, 23.14,
115.95, 126.29, 127.43, 128.71, 130.93, 135.97, 137.90,
138.74, 139.29; Anal. Calcd for C14H16N2: C 79.21; H
7.60; N 13.20; found: C 79.04; H 7.88; N 13.00.
3.2.8. 1-Phenyl-4,5,6,7,8,9-hexahydro-1H-cyclooctapyra-
zole (3k). Oil; 1H NMR (400 MHz, CDCl3) d 1.46–1.55 (m,
4H), 1.64–1.73 (m, 4H), 2.61–2.64 (m, 2H), 2.72–2.75 (m,
2H), 7.34–7.47 (m, 6H); 13C NMR (100 MHz, CDCl3)
d 22.90, 23.52, 25.42, 25.71, 28.87, 30.44, 119.71, 125.25,
127.54, 128.96, 139.59, 140.18, 140.36; Anal. Calcd for
C15H18N2: C 79.61; H 8.02; N 12.38; found: C 79.40; H
8.16; N 12.22.
3.2.2. 1-(3-Methylphenyl)-4,5,6,7-tetrahydro-1H-inda-
zole (3c). Oil; H NMR (400 MHz, CDCl3) d 1.74–1.82
1
(m, 4H), 2.39 (s, 3H), 2.56–2.59 (m, 2H), 2.70–2.72 (m,
2H), 7.10 (d, J¼7.5 Hz, 1H), 7.24–7.34 (m, 3H), 7.45 (s,
1H); 13C NMR (100 MHz, CDCl3) d 21.14, 21.80, 23.22,
23.57, 24.08, 118.00, 120.33, 124.25, 127.76, 129.10,
138.54, 139.03, 139.49, 140.43; Anal. Calcd for
C14H16N2: C 79.21; H 7.60; N 13.20; found: C 78.98; H
7.85; N 13.13.
3.2.9. 5-Naphthalen-2-yl-1-phenyl-1H-pyrazole (3o). Oil;
1H NMR (400 MHz, CDCl3) d 6.60 (d, J¼1.5 Hz, 1H),
7.22–7.34 (m, 6H), 7.45–7.50 (m, 2H), 7.70–7.80 (m, 5H);
13C NMR (100 MHz, CDCl3) d 108.62, 125.59 (ꢂ2),
126.75, 126.94, 127.05, 127.85, 128.11, 128.34, 128.46,
128.57, 129.36, 133.17, 133.50, 140.59, 140.83, 143.37;
Anal. Calcd for C19H14N2: C 84.42; H 5.22; N 10.36; found:
C 84.54; H 5.33; N 9.91.
3.2.3. 1-(4-Methylphenyl)-4,5,6,7-tetrahydro-1H-inda-
zole (3d). Oil; H NMR (400 MHz, CDCl3) d 1.74–1.82
1
(m, 4H), 2.37 (s, 3H), 2.56–2.59 (m, 2H), 2.67–2.70 (m,
2H), 7.22 (d, J¼8.0 Hz, 2H), 7.34–7.38 (m, 2H), 7.44 (s,
1H); 13C NMR (100 MHz, CDCl3) d 20.74, 20.99, 22.84,
3.2.10. 5-Ethyl-4-methyl-1-phenyl-1H-pyrazole (3q). Oil;
1H NMR (400 MHz, CDCl3) d 1.28 (t, J¼7.5 Hz, 3H), 2.08